The K562 cell line comprises immortalized human cells widely used in biomedical research, including leukemia, apoptosis, and cancer immunotherapy. K562 cells originate from an adult patient with chronic myelogenous leukemia (CML). The cells are non-adherent, appear smooth and rounded, and contain some physical features of undifferentiated leukemic cells and granulocytic leukemic cells. They are reported to spontaneously develop characteristics similar to early-stage erythrocytes, granulocytes and monocytes. The K562 cell line has been notably used in large-scale CRISPR/Cas9 gene-targeting screens. Recombinant K562 cells with genetic modifications, such as constitutive genes or knockouts have also been generated for research use. Visit the cell supplier page for more information.
Your search returned 24 K562 Cell Lines across 7 suppliers.
Select up to 5 products from below to compare or request more information.
Sponsored Products
- Recombinant K562 cells constitutively expressing firefly (Photinus pyralis) luciferase under the ...
- 1. In vitro and in vivo Bioluminescence Imaging
2. Use as a ... - 2 vials
Read More
- The K562 GFP cell line is transformed from K562 cell, expressing the GFP gene. The cell ...
- Inquire
- 1 vial
- The K562 Luciferase cell line is transformed from K562 cell, expressing the firefly luciferase gene....
- Inquire
- 1 vial
- K562-GFP cell line is constructed by stable integration of GFP encoding gene into K562 cell genome. ...
- Inquire
- Inquire
- This cell is a stable cell line with a homozygous knockout of human B2M using CRISPR/Cas9
- Inquire
- Inquire
- This cell is a stable cell line with a homozygous knockout of human CD47 using CRISPR/Cas9
- Inquire
- Inquire
- This cell is a stable cell line with a homozygous double knockout of human CD47 and B2M using CRISPR...
- Inquire
- Inquire
- This cell is a stable cell line with a homozygous knockout of human RAPSN using CRISPR/Cas9
- Inquire
- Inquire
- This cell is a stable cell line with a homozygous knockout of human SET using CRISPR/Cas9
- Inquire
- Inquire
- Creative Biolabs' bioluminescent light-producing oncology cell lines are labeled with luciferase or ...
- Inquire
- Inquire
- Creative Biolabs' bioluminescent light-producing oncology cell lines are labeled with luciferase or ...
- In Vivo Imaging
- Inquire
- K562 cells which are CD19-negative are generated using lentiviral GFP transduction. These cells can ...
- These cells are CD19-negative and can be used as a negative ...
- Inquire
Read More
Cytion (A brand of CLS Cell Lines Service GmbH)
- The K562 cell line, originating from the bone marrow of a 53-year-old female with chronic ...
- Inquire
- one cryovial
- KILR® Cytotoxicity
- Cell Pool
- The drug resistant cell line K562 AZQ has been developed from the parent K562 cell line by treatment...
- Inquire
- 1.0 mL
- Subline of K562. Resistant to adriamycin
- Inquire
- Inquire
- Methotrexate(MTX)-resistant K562 cell line
- Inquire
- Inquire
- K562-ATG10 cell line is a stable cell line with a homozygous knockout of ATG10
- Inquire
- 1.0 ML
- This cell line is engineered to stably express GFP and luciferase repoter genes. It is a useful tool...
- Inquire
- 1.0 ML
- K562-Luciferase cell line stably overexpresses luciferase as a reporter of K562 cells. It is a good ...
- Inquire
- 1.0 ML
- This cell line is derived from K562 which is engineered to stably erexpress luciferase reporter gene...
- Inquire
- 1.0 ML
- K562-TMEM187 cell line is a stable cell line with a homozygous knockout of TMEM187
- Inquire
- 1.0 ML
Select up to 5 products from above to compare or request more information.
Tags:
Please Login or Register to Create Tags